Yuanhuadin
Yuanhuadin, extracted from Genkwa Flos Daphne genkwa, has antitumor activity through inhibiting Akt/mTOR and EGFR pathways, induce cell-cycle arrest and abortion.
For research use only. We do not sell to patients.
- CAS No.: 76402-66-9
- Formula: C32H42O10
- Molecular Weight:586.67
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All EGFR Isoforms
More
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
>50 μM
Compound: 9
|
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
Cytotoxicity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 23558238] |
| A549 | IC50 |
12 nM
Compound: 1
|
Antiproliferative activity against human A549 cells after 3 days by SRB assay
Antiproliferative activity against human A549 cells after 3 days by SRB assay
|
[PMID: 21916433] |
| B16 | IC50 |
0.06 μM
Compound: 4
|
Inhibition of melanin production in alpha-MSH stimulated mouse B16 cells after 72 hrs by spectrophotometry
Inhibition of melanin production in alpha-MSH stimulated mouse B16 cells after 72 hrs by spectrophotometry
|
[PMID: 23623417] |
| B16 | IC50 |
22 μM
Compound: 4
|
Cytotoxicity against alpha-MSH stimulated mouse B16 cells after 72 hrs by MTT assay
Cytotoxicity against alpha-MSH stimulated mouse B16 cells after 72 hrs by MTT assay
|
[PMID: 23623417] |
| HCT-116 | IC50 |
10.2 μM
Compound: 1
|
Antiproliferative activity against human HCT116 cells after 3 days by SRB assay
Antiproliferative activity against human HCT116 cells after 3 days by SRB assay
|
[PMID: 21916433] |
| HCT-116 | IC50 |
32.65 μM
Compound: 9
|
Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay
Cytotoxicity against human HCT116 cells after 48 hrs by MTT assay
|
[PMID: 23558238] |
| HeLa | IC50 |
17.06 μM
Compound: 9
|
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 23558238] |
| HepG2 | IC50 |
26.27 μM
Compound: 9
|
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 23558238] |
| HL-60 | IC50 |
30.05 μM
Compound: 9
|
Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
Cytotoxicity against human HL60 cells after 48 hrs by MTT assay
|
[PMID: 23558238] |
| HT-1080 | IC50 |
<0.1 μM
Compound: 9
|
Cytotoxicity against human HT1080 cells after 48 hrs by MTT assay
Cytotoxicity against human HT1080 cells after 48 hrs by MTT assay
|
[PMID: 23558238] |
| K562 | IC50 |
22.16 μM
Compound: 9
|
Cytotoxicity against human K562 cells after 48 hrs by MTT assay
Cytotoxicity against human K562 cells after 48 hrs by MTT assay
|
[PMID: 23558238] |
| LoVo | IC50 |
>10 μM
Compound: 10
|
Cytotoxicity against human LoVo cells after 24 hrs by MTT assay
Cytotoxicity against human LoVo cells after 24 hrs by MTT assay
|
[PMID: 32223193] |
| MCF7 | IC50 |
4.11 μM
Compound: 9
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 23558238] |
| MT4 | CC50 |
>6.8 μM
Compound: 14
|
Cytotoxicity against human MT4 cells incubated for 3 days by CellTiter-Glo luminescent assay
Cytotoxicity against human MT4 cells incubated for 3 days by CellTiter-Glo luminescent assay
|
[PMID: 31860304] |
| NCI-H1299 | IC50 |
5.6 μM
Compound: 1
|
Antiproliferative activity against human H1299 cells after 3 days by SRB assay
Antiproliferative activity against human H1299 cells after 3 days by SRB assay
|
[PMID: 21916433] |
| NCI-H1993 | IC50 |
4.1 nM
Compound: 1
|
Antiproliferative activity against gefitinib resistant human NCI-H1993 cells after 3 days by SRB assay
Antiproliferative activity against gefitinib resistant human NCI-H1993 cells after 3 days by SRB assay
|
[PMID: 21916433] |
| NCI-H1993 | IC50 |
4.7 nM
Compound: 1
|
Antiproliferative activity against human NCI-H1993 cells after 3 days by SRB assay
Antiproliferative activity against human NCI-H1993 cells after 3 days by SRB assay
|
[PMID: 21916433] |
| NCI-H292 | IC50 |
<1 x 10-6μM
Compound: 1
|
Antiproliferative activity against gefitinib resistant human NCI-H292 cells after 3 days by SRB assay
Antiproliferative activity against gefitinib resistant human NCI-H292 cells after 3 days by SRB assay
|
[PMID: 21916433] |
| NCI-H292 | IC50 |
<1 x 10-6μM
Compound: 1
|
Antiproliferative activity against human NCI-H292 cells after 3 days by SRB assay
Antiproliferative activity against human NCI-H292 cells after 3 days by SRB assay
|
[PMID: 21916433] |
| NCI-H358 | IC50 |
9.1 μM
Compound: 1
|
Antiproliferative activity against human NCI-H358 cells after 3 days by SRB assay
Antiproliferative activity against human NCI-H358 cells after 3 days by SRB assay
|
[PMID: 21916433] |
| PC-3 | IC50 |
7.4 μM
Compound: 1
|
Antiproliferative activity against human PC3 cells after 3 days by SRB assay
Antiproliferative activity against human PC3 cells after 3 days by SRB assay
|
[PMID: 21916433] |
| RKO | IC50 |
>10 μM
Compound: 10
|
Cytotoxicity against human RKO cells after 24 hrs by MTT assay
Cytotoxicity against human RKO cells after 24 hrs by MTT assay
|
[PMID: 32223193] |
| SK-HEP1 | IC50 |
12.9 μM
Compound: 1
|
Antiproliferative activity against human SKHEP1 cells after 3 days by SRB assay
Antiproliferative activity against human SKHEP1 cells after 3 days by SRB assay
|
[PMID: 21916433] |
| SK-MES-1 | IC50 |
<1 x 10-6μM
Compound: 1
|
Antiproliferative activity against human SK-MES cells after 3 days by SRB assay
Antiproliferative activity against human SK-MES cells after 3 days by SRB assay
|
[PMID: 21916433] |
| SNU-638 | IC50 |
>20 μM
Compound: 1
|
Antiproliferative activity against human SNU638 cells after 3 days by SRB assay
Antiproliferative activity against human SNU638 cells after 3 days by SRB assay
|
[PMID: 21916433] |
| SW480 | IC50 |
11.8 μM
Compound: 1
|
Antiproliferative activity against human SW480 cells after 3 days by SRB assay
Antiproliferative activity against human SW480 cells after 3 days by SRB assay
|
[PMID: 21916433] |
| SW-620 | IC50 |
>10 μM
Compound: 10
|
Cytotoxicity against human SW620 cells after 24 hrs by MTT assay
Cytotoxicity against human SW620 cells after 24 hrs by MTT assay
|
[PMID: 32223193] |
| T47D | IC50 |
12.7 μM
Compound: 1
|
Antiproliferative activity against human T47D cells after 3 days by SRB assay
Antiproliferative activity against human T47D cells after 3 days by SRB assay
|
[PMID: 21916433] |
| U-937 | IC50 |
14.66 μM
Compound: 9
|
Cytotoxicity against human U937 cells after 48 hrs by MTT assay
Cytotoxicity against human U937 cells after 48 hrs by MTT assay
|
[PMID: 23558238] |
Chemical Information
-
CAS No. 76402-66-9
-
Molecular Weight 586.67
-
Formula C32H42O10
-
SMILES
O=C1C(C)=C[C@@H]2[C@]3([C@H]4[C@H]5O[C@@]5([C@H]([C@@]12O)O)CO)O[C@]6(O[C@@]([C@@H](OC(C)=O)[C@H]3C)([C@H]4O6)C(C)=C)/C=C/C=C/CCCCC
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Subcutaneous Cell-Line-Derived Xenograft
Subcutaneous cell-line-derived xenograft (CDX) models are established by implanting cultured human cancer cell lines into immunodeficient mice, where the injected cells form localized tumors that can be monitored in vivo as a measure of tumorigenic potential, growth kinetics, and treatment response. These models are widely used in oncology research because they allow reproducible tumor formation and enable comparative assessment of tumor growth between different cell lines or genetic manipulations in a controlled in vivo microenvironment. Subcutaneous implantation of cancer cells in immunodeficient mice is a standard approach for evaluating tumor growth behavior and therapeutic response across multiple cancer types, including prostate, esophageal, pancreatic, and colon cancer models.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)